Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DeLiver Pharma ApS
APS
Active
Advertising protection
CVR 39432714
Sanatorievej 8, 5600
Faaborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
DeLiver Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-20
-22
-18
119
-10
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-20
-22
-18
119
-10
Depreciation & amort.
-94
-125
-11
-11
-11
EBIT
-114
-147
-29
107
-22
Net financials
0
0
0
0
0
Profit before tax
-114
-147
-29
107
-22
Tax
-0
-0
-0
-0
-0
Net profit
-114
-147
-29
107
-22
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
255
150
121
271
206
Equity
246
139
109
217
195
Long-term debt
0
0
0
0
0
Short-term debt
9
11
11
55
11
Total debt
9
11
11
55
11
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1030200.0%
This company
2020
2024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
2020
2024
Return on equity
-11.1%
This company
18.4%
Market median
-160% vs market
2020
2024
Net profit margin (of gross profit)
-2168200.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.05×
This company
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on DeLiver Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
